japanes
enceph
viru
jev
member
mosquitoborn
flavivirus
envelop
positivesens
singlestrand
rna
viru
like
flavivirus
includ
dengu
viru
west
nile
viru
zika
viru
jev
genom
open
read
frame
orf
encod
polyprotein
consist
structur
protein
capsid
c
membran
prmm
envelop
e
nonstructur
protein
c
protein
contain
posit
charg
residu
enabl
bind
viral
rna
form
ribonucleoprotein
complex
signal
peptid
prmm
protein
slice
cell
proteas
matur
e
protein
e
respons
viru
attach
membran
fusion
also
crucial
antigen
induc
neutral
antibodi
nonstructur
protein
respons
viral
replic
protein
associ
initi
negativestrand
rna
synthesi
earli
stage
replic
secret
modul
host
immun
respons
membran
associ
protein
particip
viru
replic
assembl
cofactor
activ
proteolyt
activ
protein
contain
proteas
helicas
ntpase
domain
hydrophob
protein
also
relat
viral
replic
block
interferon
signal
moreov
recogn
rnadepend
rna
polymeras
methyltransferas
jev
infect
might
lead
develop
perman
neurolog
psychiatr
sequela
includ
memori
loss
behavior
disturb
impair
cognit
convuls
paralysi
sever
central
nervou
system
damag
jev
predomin
southeast
asia
east
asia
due
distribut
culex
speci
although
inactiv
jev
genotyp
iii
vaccin
invent
introduc
mani
countri
je
case
includ
death
annual
report
area
recent
genotyp
jev
appear
vietnam
taiwan
china
korea
potenti
becom
predomin
genotyp
countri
notic
inactiv
jev
genotyp
iii
vaccin
elicit
low
protect
immun
jev
genotyp
nowaday
still
effect
treatment
yet
je
case
rapid
ration
screen
platform
necessari
effici
develop
antijev
agent
replicon
positivestrand
rna
virus
hepat
c
viru
coronaviru
dengu
viru
west
nile
viru
jev
use
screen
antivir
compound
examin
antivir
mechan
replicon
contain
partial
genom
includ
cisact
element
well
gene
nonstructur
protein
control
cytomegaloviru
cmv
immediateearli
promot
cmv
promot
driven
viral
rna
subgenom
enabl
selfrepl
transfect
cell
infecti
particl
moreov
report
gene
like
green
fluoresc
protein
gfp
firefli
luciferas
infram
clone
viral
subgenom
replicon
quantit
analysi
report
express
becom
measur
assay
monitor
viru
replic
dnalaunch
replicon
conveni
rnalaunch
replicon
requir
produc
viral
rna
subgenom
use
vitro
transcript
assay
lack
structur
protein
code
region
type
viru
replicon
transient
selfrepl
cell
post
transfect
could
gener
infecti
particl
analyz
earli
stage
viral
replic
subsequ
dnalaunch
replicon
transfect
cell
carri
recombin
plasmid
encod
viral
structur
protein
express
structur
protein
selfrepl
viral
subgenom
gener
singleround
infecti
particl
srip
sever
flaviviru
repliconbas
srip
includ
jev
dengu
viru
west
nile
viru
tickborn
enceph
viru
gener
demonstr
immunogen
viruslik
particl
report
recogn
repliconbas
srip
suitabl
system
develop
safer
vaccin
flaviviru
infect
repliconbas
srip
contain
report
gene
fluoresc
protein
could
applic
rapid
realtim
screen
antivir
agent
well
directli
quantit
antivir
activ
condit
without
plaquebas
assay
studi
intend
establish
safe
reliabl
platform
screen
antivir
agent
investig
antivir
mechan
use
jev
repliconbas
srip
flow
cytometri
figur
report
enhanc
green
fluoresc
protein
egfp
fuse
footandmouth
diseas
viru
fmdv
peptid
clone
infram
fuse
code
region
plasmidbas
jevegfp
replicon
name
subsequ
jevegfp
srip
gener
cell
cotransfect
infect
jevegfp
srip
character
replic
viral
subgenom
express
egfp
well
viral
protein
use
realtim
pcr
fluoresc
microscopi
final
antivir
screen
platform
perform
accord
compar
fluoresc
intens
egfp
sripinfect
cell
without
treatment
flow
cytometri
accuraci
reproduc
half
maxim
inhibitori
concentr
antijev
agent
jevegfp
srip
plu
flow
cytometri
evalu
use
plaquereduct
assay
human
medulloblastoma
cell
cultur
minimum
essenti
medium
mem
ge
healthcar
life
scienc
pittsburgh
pa
usa
fetal
bovin
serum
thermofish
waltham
usa
glutamin
pyruv
penicillinstreptomycin
atmospher
contain
carbon
dioxid
jev
strain
genbank
use
studi
propag
cell
describ
prior
report
plasmid
deriv
thermofish
waltham
usa
insert
nucleotid
linker
contain
ecori
kpni
noti
xhoi
ecori
ecoribamhi
site
figur
result
use
vector
assembl
fragment
jevegfp
replicon
consist
five
nucleotid
nt
fragment
includ
cmv
immediateearli
promot
nt
jev
strain
genbank
egfpfmdv
peptid
nt
strainhepat
delta
viru
ribozym
hdvr
polya
figur
fragment
amplifi
use
pcr
supermix
high
fidel
reaction
life
technolog
carlsbad
ca
usa
indic
primer
pair
templat
list
supplement
tabl
forward
primer
fragment
extra
nucleotid
sequenc
flag
tag
clai
restrict
site
revers
primer
fragment
contain
extra
nucleotid
sequenc
fmvd
peptid
hdvr
respect
infram
fusion
fragment
produc
use
jump
pcr
method
figur
clone
kpni
noti
site
sinc
uniqu
apai
restrict
site
jev
fragment
ligat
apai
noti
doubl
digest
subsequ
fragment
clone
xhoibamhi
notixhoi
site
assembl
jevegfp
replicon
five
fragment
propag
e
coli
cell
verifi
restrict
enzym
analysi
plu
sequenc
examin
synthesi
posit
negativesens
rna
subgenom
total
rna
transfect
cell
jevegfp
replicon
extract
use
purelink
mini
total
rna
purif
kit
thermofish
waltham
usa
revers
transcript
cdna
specificcaptur
primer
follow
measur
posit
negativesens
rna
subgenom
use
sybr
greenbas
real
time
pcr
jevspecif
primer
pair
figur
rel
level
rna
subgenom
normal
glyceraldehyd
dehydrogenas
gapdh
describ
prior
report
explor
express
egfp
jev
protein
transfect
cell
rins
pb
fix
formaldehyd
pb
room
temperatur
min
permeabil
triton
bsa
pb
room
temperatur
hr
block
bovin
serum
albumin
pb
permeabil
cell
stain
use
primari
rabbit
polyclon
antibodi
includ
antijev
e
protein
antijev
antijev
genetex
inc
irvin
ca
usa
follow
incub
secondari
goat
antirabbit
igg
thermofish
waltham
usa
dark
box
h
wash
pb
stain
cell
photograph
use
immunofluoresc
microscopi
olympu
tokyo
japan
construct
recombin
plasmid
express
jev
structur
protein
mammalian
cell
code
region
jev
structur
protein
amplifi
use
pcr
clone
ecori
xbai
site
express
plasmid
figur
figur
result
plasmid
analyz
use
restrict
enzym
analysi
sequenc
primer
sequenc
list
supplement
tabl
mutat
detect
creat
packag
cell
line
express
jev
structur
protein
cell
grown
confluenc
sixwel
plate
transfect
use
lipofectamin
ltx
invitrogen
carlsbad
ca
usa
accord
manufactur
guidelin
transfect
cell
treat
h
post
transfect
stabl
transfect
cell
line
establish
express
jev
structur
protein
valid
immunofluoresc
stain
next
packag
cell
line
grown
confluenc
transfect
replicon
use
lipofectamin
ltx
jevegfp
srip
collect
cultur
media
lysat
supernat
transfect
packag
cell
final
viral
subgenom
synthesi
viral
protein
express
infect
cell
examin
use
real
time
rtpcr
immunofluoresc
stain
describ
determin
infect
jevegfp
srip
cprmepackag
cell
infect
srip
harvest
h
post
infect
wash
pb
centrifug
rpm
min
cell
pellet
dissolv
pb
fix
ml
alcohol
overnight
wash
twice
pb
next
day
resuspend
cell
analyz
bd
facsaria
becton
dickinson
franklin
lake
nj
usa
excit
nm
emiss
nm
mockinfect
cprme
packag
cell
serv
neg
control
fluoresc
intens
set
threshold
result
record
ratio
egfpposit
cell
total
cell
green
fluoresc
intens
posit
cell
respect
compound
methyl
oxi
acet
synthes
base
lead
compound
figur
antineoplast
quinazolinon
deriv
introduc
function
group
alkoxyl
anilin
moieti
quinazolino
decreas
cytotox
g
mmol
synthes
accord
publish
procedur
dissolv
ml
n
ndimethylformamid
dmf
treat
sodium
hydrid
nah
dispers
paraffin
oil
merck
min
methyl
chloroacet
g
mmol
lancast
ad
suspens
stir
h
mixtur
pour
ice
water
ml
filter
collect
brown
precipit
precipit
wash
water
dri
purifi
column
chromatographi
silica
gel
dichloromathanenhexan
recrystal
ethanol
afford
yield
g
brown
crystal
ident
puriti
confirm
nuclear
magnet
reson
spectroscopi
mass
spectrum
melt
point
determin
yanaco
melt
point
apparatu
uncorrect
nuclear
magnet
reson
nmr
spectra
obtain
bruker
avanc
nmr
spectromet
waltham
usa
dimethyl
sulfoxid
dmso
follow
abbrevi
use
singlet
doublet
dd
doubl
doublet
triplet
q
quartet
multiplet
br
broad
mass
spectrometri
ms
spectra
measur
finniganthermo
quest
mat
instrument
waltham
usa
element
analys
c
h
n
perform
perkinelm
seri
ii
chnso
analyz
waltham
usa
elementar
vario
el
iii
heraeu
chno
rapid
langenselbold
hess
germani
result
within
calcul
valu
melt
point
nmr
j
hz
dd
j
hz
j
hz
j
hz
j
hz
ppm
nmr
ppm
ms
esi
mz
anal
c
h
n
cytotox
cell
measur
use
mtt
assay
cell
treat
quadrupl
h
incub
mgml
mtt
solut
h
dissolv
dmso
absorb
detect
use
microelisa
reader
surviv
rate
calcul
ratio
treat
cell
mock
cell
cytotox
concentr
give
calcul
comput
program
describ
prior
report
cell
infect
jev
multipl
infect
moi
simultan
treat
photo
jevinduc
cytopath
effect
infect
cell
taken
invert
microscop
h
post
infect
moreov
mock
cell
infect
jevegfp
srip
treat
h
post
transfect
express
egfp
viral
protein
well
synthesi
posit
negativesens
rna
subgenom
infect
cell
determin
use
fluoresc
microscop
immunofluoresc
stain
realtim
rtpcr
assay
describ
jev
cprmeexpress
packag
cell
infect
jevegfp
srip
presenc
absenc
incub
treat
infect
cell
wash
trypsin
collect
centrifug
rpm
min
fix
ml
alcohol
overnight
analyz
bd
facsaria
becton
dickinson
excit
nm
emiss
nm
valu
calcul
accord
chang
ratio
green
fluoresc
intens
green
fluoresc
posit
treatedinfect
cell
untreat
infect
cell
respect
monolay
cell
plate
infect
jev
pfu
simultan
treat
incub
plaqu
quantifi
stain
naphthol
blueblack
dye
inhibitori
concentr
show
jev
plaqu
reduct
calcul
use
plaqu
reduct
data
three
independ
experi
virucid
assay
mixtur
jev
pfu
per
reaction
indic
concentr
incub
h
dilut
mixtur
ad
onto
cell
monolay
follow
protocol
plaqu
assay
viru
attach
assay
mixtur
jev
pfu
per
well
immedi
ad
onto
cell
monolay
h
wash
cold
pb
cell
monolay
follow
protocol
plaqu
assay
virucid
attach
inhibit
activ
calcul
residu
plaqu
piec
data
three
independ
experi
repres
mean
standard
deviat
sd
group
evalu
student
ttest
pvalu
lower
comparison
recogn
statist
signific
jevegfp
replicon
consist
five
fragment
selfrepl
e
coli
verifi
use
restrict
endonucleas
fragment
nucleotid
sequenc
analys
size
result
restrict
fragment
use
singl
doubledigest
match
given
restrict
map
jevegfp
replicon
moreov
nucleotid
sequenc
analysi
sequencespecif
primer
tabl
indic
synonym
mutat
nonsynonym
mutat
identifi
jevegfp
replicon
nearli
ident
jev
parent
strain
nucleotid
ident
amino
acid
ident
tabl
examin
function
properti
jevegfp
replicon
vitro
viral
genom
transcript
translat
replicon
human
medulloblastoma
cell
character
figur
figur
rel
copi
number
posit
negativesens
jev
subgenom
measur
use
realtim
revers
transcriptionpcr
specif
captur
amplif
primer
normal
housekeep
gene
gapdh
figur
figur
copi
number
positivesens
jev
subgenom
copi
transfect
cell
jevegfp
replicon
h
post
transfect
meanwhil
copi
number
negativesens
jev
subgenom
detect
late
stage
jev
replic
replicontransfect
cell
ratio
posit
negativesens
rna
synthesi
greater
impli
highli
effici
selfrepl
viral
genom
replicontransfect
cell
addit
fluoresc
microscopi
reveal
green
fluoresc
replicontransfect
cell
indic
express
replicondriven
egfp
immunofluoresc
stain
also
demonstr
synthesi
viral
protein
like
transfect
cell
figur
interestingli
cytopath
effect
cpe
observ
replicontransfect
mock
cell
replicontransfect
packag
cell
mock
cell
packag
cell
figur
addit
cpe
level
higher
replicontransfect
packag
cell
replicontransfect
mock
cell
associ
lower
amount
e
replicontransfect
packag
cell
compar
replicontransfect
mock
cell
jev
nonstructur
protein
like
abund
egfp
late
stage
jev
replicon
replic
mock
cell
result
show
plasmidbas
jev
replicon
enabl
product
selfrepl
jev
rna
genom
viral
nonstructur
protein
cell
gener
packag
cell
line
product
jevegfp
srip
stabli
transfect
cell
line
select
longperiod
screen
express
jev
structur
protein
e
protein
stabli
transfect
packag
cell
line
detect
use
immunofluoresc
stain
figur
subsequ
jevegfp
replicon
transfect
packag
cell
line
realtim
rtpcr
immunofluoresc
stain
demonstr
jevegfp
replicondriven
viral
posit
negativesens
rna
genom
synthes
well
replicondriven
egfp
viral
nonstructur
protein
express
packag
cell
line
figur
figur
copi
number
positivesens
jev
subgenom
copi
packag
cell
transfect
jev
replicon
h
post
transfect
copi
number
negativesens
jev
subgenom
also
detect
late
stage
jev
replic
replicontransfect
packag
cell
ratio
posit
negativesens
rna
synthesi
greater
impli
higher
effici
selfrepl
replicondriven
viral
subgenom
packag
cell
compar
mock
cell
immunofluoresc
stain
indic
amount
viral
protein
e
lower
packag
cell
transfect
jevegfp
replicon
untransfect
packag
cell
mock
cell
transfect
replicon
associ
cytopath
effect
replicontransfect
packag
cell
due
gener
jevegfp
srip
therefor
jevegfp
srip
harvest
supernat
lysat
replicontransfect
packag
cell
h
post
transfect
examin
infect
jevegfp
srip
vitro
packag
cell
infect
jevegfp
srip
sripinduc
cytopath
effect
sripdriven
egfp
packag
cell
observ
h
post
infect
figur
green
fluoresc
intens
mockinfect
sripinfect
cell
quantit
use
flow
cytometri
figur
sripinfect
cell
signific
increas
ratio
green
fluorescenceposit
cell
accumul
fluoresc
intens
compar
mockinfect
cell
figur
result
demonstr
product
infecti
srip
cotransfect
cell
quantit
analysi
srip
infect
use
flow
cytometri
access
whether
jevegfp
srip
could
applic
antivir
assay
substitut
jev
virion
combin
jevegfp
srip
flow
cytometri
use
evalu
valu
compound
jev
compar
plaqu
reduct
assay
wild
type
virion
figur
figur
quinazolinon
deriv
low
cytotox
figur
supplement
figur
serv
signific
inhibit
jevinduc
cytopath
effect
cell
respect
figur
effect
virucid
activ
viru
attach
inhibit
figur
moreov
concentrationdepend
reduc
express
egfp
viral
protein
like
sripinfect
mock
cell
also
suppress
synthesi
positivesens
rna
subgenom
sripinfect
mock
cell
h
post
treatment
figur
demonstr
significantli
decreas
effici
selfrepl
replicondriven
viral
subgenom
examin
antijev
abil
use
jevegfp
srip
cprmeexpress
packag
cell
subsequ
infect
srip
simultan
treat
without
figur
significantli
inhibit
sripinduc
cytopath
effect
reduc
express
green
fluoresc
protein
sripinfect
packag
cell
figur
green
fluoresc
uninfect
packag
cell
sripinfect
packag
cell
analyz
use
flow
cytometri
figur
c
valu
jev
base
green
fluorescenceposit
cell
accord
accumul
fluoresc
intens
respect
figur
c
comparison
jevegfp
srip
wild
type
virion
use
examin
antijev
abil
convent
plaqu
assay
valu
figur
result
indic
antivir
assay
combin
jevegfp
srip
flow
cytometri
enabl
measur
valu
antivir
agent
sensit
plaqu
reduct
assay
jev
virion
cmv
promoterlaunch
replicon
need
either
vitro
transcript
step
requir
promoterlaunch
replicon
cotransfect
plasmid
contain
rna
polymeras
promoterlaunch
replicon
moreov
dnadepend
rna
polymeras
higher
fidel
rnadepend
rna
polymeras
thu
studi
construct
cmv
promoterlaunch
jev
replicon
carri
green
fluoresc
report
egfp
figur
figur
howev
clone
process
jev
fulllength
infecti
clone
replicon
reveal
nonsens
mutat
nt
nt
delet
nt
appear
onethird
nt
jev
genom
data
shown
importantli
nonsens
mutat
delet
identifi
result
product
truncat
protein
loss
e
protein
cell
find
indic
prokaryot
promot
activ
onethird
jev
genom
direct
synthesi
structur
protein
c
prmm
e
might
toxic
gene
protein
bacteria
toxic
sequenc
especi
region
encod
prm
protein
correl
genet
instabl
jev
infecti
clone
replicon
e
coli
find
similar
previou
report
sever
e
coli
promot
sequenc
identifi
within
end
jev
genom
particularli
nt
sinc
restrict
enzym
apai
site
locat
jev
genom
nt
nucleotid
jev
genom
encod
eight
amino
acid
c
protein
fuse
egfp
report
gene
cmv
promoterlaunch
jev
replicon
addit
addit
restrict
enzym
sequenc
noti
clai
encod
partial
ctermin
transmembran
amino
acid
e
protein
allow
two
uniqu
restrict
enzym
site
dnabas
jev
replicon
could
use
express
vector
mammalian
cell
therefor
cmv
promoterlaunch
jevegfp
replicon
contain
toxic
sequenc
encod
prm
protein
allow
stabil
jev
cdna
clone
bacteria
addit
recombin
plasmid
nucleotid
sequenc
jev
genom
encod
structur
protein
c
prmm
e
stabl
bacteria
due
lack
prokaryot
promot
nt
pflagcmvcprm
exhibit
plasmid
stabil
e
coli
plasmid
low
copi
number
plasmid
chosen
jev
replicon
vector
plasmid
jevegfp
replicon
genet
stabl
e
coli
exhibit
high
nucleotid
amino
acid
ident
tabl
replicon
also
higher
yield
ecoli
cosmid
vector
bacteri
artifici
chromosom
offer
effect
effici
approach
manipul
clone
viral
gene
among
nonsil
mutat
replicon
compar
origin
genom
sequenc
jev
strain
eight
mutat
residu
appear
within
three
mutat
occur
within
tabl
eight
mutat
replicon
relat
activ
site
conserv
motif
proteas
helicas
well
methyltransferas
rnadepend
rna
polymeras
base
structur
function
analysi
flavivir
nonstructur
protein
addit
amino
acid
substitut
replicon
sporad
exist
within
match
report
mutat
site
alter
jev
replic
find
suggest
mutat
replicon
might
signific
effect
viru
replic
function
character
jevegfp
replicon
indic
signific
increas
green
fluoresc
intens
replicontransfect
cell
figur
moreov
percentag
yellow
fluoresc
intens
cell
much
higher
percentag
green
fluoresc
intens
egfpexpress
cell
post
transfect
jevegfp
replicon
result
might
associ
loss
quench
effect
egfp
fluoresc
fixat
process
stain
cell
paraformaldehyd
ethanol
methanol
moreov
synthesi
posit
negativesens
rna
subgenom
well
express
jev
protein
detect
replicontransfect
cell
figur
figur
jevegfp
replicon
contain
cmv
immediateearli
promot
well
hdvr
termin
polyadenyl
sequenc
allow
product
function
jev
subgenom
figur
figur
figur
pflagcmvcprm
util
establish
packag
cell
line
continu
express
c
prmm
e
protein
allow
product
jev
srip
h
post
transient
transfect
jevegfp
replicon
figur
figur
figur
therefor
produc
jev
srip
altern
approach
overcom
obstacl
genet
instabl
jev
infecti
clone
use
fulllength
cdna
sequenc
although
still
question
whether
mutat
affect
genom
replic
effici
jevegfp
replicon
srip
gener
studi
could
use
screen
antivir
agent
antivir
activ
identifi
agent
might
confirm
use
wild
type
jev
virion
egfp
report
realtim
function
marker
genom
replic
viral
protein
express
jevegfp
replicon
mock
cell
srip
packag
cell
detect
use
fluoresc
microscop
figur
figur
figur
fluoresc
intens
posit
sripinfect
cell
quantit
use
flow
cytometri
figur
reason
low
egfpposit
percentag
fluoresc
intens
untreat
sripinfect
cell
could
low
infecti
dose
srip
loss
egfp
fluoresc
fixat
ethanol
highli
stringent
threshold
posit
green
fluoresc
infect
cell
increas
egfpposit
cell
without
treatment
elev
moi
use
assay
fluoresc
intens
infect
cell
directli
measur
use
fluoresc
micropl
reader
condit
without
fixat
agent
screen
assay
identifi
antivir
agent
figur
base
total
fluoresc
intens
show
near
line
neg
slope
antivir
activ
jev
figur
base
green
fluoresc
posit
sinc
plaqu
reduct
assay
laborintens
timeconsum
safe
keep
combin
jevegfp
srip
flow
cytometri
might
easi
rapid
safer
approach
determin
valu
antivir
agent
comparison
valu
jev
use
plaqu
reduct
jevegfp
srip
plu
flow
cytometri
indic
valu
jevegfp
srip
plu
flow
cytometri
lower
plaqu
reduct
assay
figur
result
demonstr
assay
jevegfp
srip
plu
flow
cytometri
sensit
plaqu
reduct
assay
show
potenti
applic
antivir
drug
screen
neutral
assay
addit
system
jevegfp
srip
packag
cell
plu
flow
cytometri
easili
observ
use
fluoresc
microscop
quantit
flow
cytometri
suggest
better
tool
compar
luciferas
report
system
approach
design
jevegfp
srip
plu
flow
cytometri
might
applic
flavivirus
dengu
zika
virus
moreov
altern
approach
quantit
replicondriven
report
activ
might
applic
highthroughput
screen
antivir
agent
combin
jevegfp
srip
fluoresc
micropl
reader
methyl
oxi
acet
quinazolinon
deriv
process
potent
antijev
activ
valu
determin
assay
jevegfp
srip
packag
cell
plu
flow
cytometri
figur
moreov
reduc
synthesi
viral
genom
express
viral
protein
figur
impli
significantli
decreas
effici
selfrepl
replicondriven
viral
subgenom
howev
affect
neither
irrevers
loss
jev
infect
virucid
activ
viru
attach
host
cell
supplement
figur
therefor
suggest
antijev
mechan
could
relat
influenc
late
stage
jev
replic
cycl
eg
viral
transcript
translat
interestingli
sever
quinazolinon
deriv
identifi
antivir
activ
broad
rang
dna
rna
virus
varicellazost
viru
cytomegaloviru
influenza
viru
hepat
c
viru
quinazolinon
deriv
potent
inhibit
replic
influenza
viru
vitro
via
suppress
viru
neuraminidas
cellular
signal
quinazolinonecontain
macrocycl
consid
nextgener
hcv
proteas
inhibitor
therefor
antivir
abil
might
examin
flavivirus
conclus
jevegfp
replicon
avoid
genet
instabl
onethird
fulllength
jev
genom
cdna
construct
lowcopi
plasmid
regul
control
cmv
promot
transfect
packag
cell
line
express
viral
structur
protein
gener
jevegfp
srip
report
gene
egfp
correl
infect
jevegfp
srip
packag
cell
easili
rapidli
util
screen
antivir
agent
use
fluoresc
microscop
combin
jevegfp
srip
plu
flow
cytometri
reliabl
effect
effici
assay
measur
valu
antivir
agent
like
base
fluoresc
intens
posit
sripinfect
packag
cell
post
treatment
